References in periodicals archive ?
The Escherichia Coli Infections therapeutics pipeline review report provides assessment information on assessment by monotherapy products, by combination products, by target, by mechanism of action, by route of administration and by molecule type.
Small Molecules for Bacterial Infections, Small Molecules for Escherichia Coli Infections,Small Molecules for Multi-Drug Resistant Gram-Positive and Gram-Negative Bacterial Infections, Small Molecules to Inhibit 23S Ribosomal RNA for Infections, Small Molecules to Inhibit 30S RNA, Topoisomerases II and IV for Bacterial Infections, Small Molecules to Inhibit RecA for Bacterial Infections, Synthetic Peptide for Oncology and Infectious Disease, Synthetic Peptide to Antagonize TLR-4 for Oncology, Immunology and Infectious Disease and Synthetic Peptides for Escherichia Coli Infections.
Coverage of the Escherichia Coli Infections pipeline on the basis of route of administration and molecule type.
The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohaemorrhagic Escherichia coli infection.
Recommendations for diagnosis of Shiga toxin--producing Escherichia coli infections by clinical laboratories.
Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
Fifth International Symposium on Shiga toxin (verocytotoxin)-producing Escherichia coli infections.
Concurrent outbreaks of Shigella sonnei and enterotoxiganic Escherichia coli infections associated with parsley: implications for surveillance and outbreak control.
Epidemiology of Shiga-toxin-producing Escherichia coli infections in continental Europe.
Importance of culture confirmation of Shiga toxin--producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005.
Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005.